TrialOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2020

Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study.

E M C Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.